Last updated on September 11th, 2021 at 02:56 pm
A new discovery could lead to better treatments for multiple sclerosis (MS) and other autoimmune diseases, such as psoriasis and rheumatoid arthritis, researchers report.
MS occurs when immune cells get into the central nervous system (the brain and spinal cord), causing nerve damage that results in neurological problems.
However, the cause is unclear. Studies in a mouse model of MS – called experimental autoimmune encephalomyelitis (EAE) – have shown that immune T-cells, which secrete an immune molecule called IL-17, damage the myelin sheath surrounding nerves in the central nervous system (CNS).
Drugs that block IL-17 have shown promise in early clinical trials for treatment of relapsing-remitting MS. The drugs have already been licensed for treating psoriasis.
Trade between African and GCC countries stands at $ 121 billion in 2023, double of what it was in 2016.…
Family members struggling after one week after of Cyclone Chido ripped through the French island territory of Mayotte expressed helplessness…
The United Arab Emirates has launched its orphanage project in Ethiopia's Oromia region on the orders of President Sheikh Mohamed…
In just four months, 100 women have been killed, the majority by males they knew including spouses. Prime Cabinet Secretary…
The Ghanaian entertainment industry is in deep mourning following the sudden death of Bright Owusu, better known as C Confion.…
Since the beginning of December more than five hundred people have lost their lives on the nation's highways. Barbara Creecy,…
This website uses cookies.